| 证券代码 | BCR.N |
| 证券名称 | 巴德集团 |
| 证券类型 | 美股 |
| 上市场所 | 纽约证券交易所 |
| 上市板块 | - |
| 发行方式 | - |
| 首发上市日 | 1968-09-30 |
| 首发价格(元) | - |
| 首发数量(股) | 0 |
| 首发募资额(元) | - |
| 首发主承销商 | - |
| 货币单位 | USD |
| 公司名称 | C. R. Bard, Inc. |
| 注册地址 | 美国新泽西州 |
| 办公地址 | 730 Central Avenue, Murray Hill, New Jersey, USA |
| 成立日期 | 1907 |
| 董事会主席 | Timothy M. Ring |
| 公司属地 | United States 美国 |
| 公司网址 | www.crbard.com |
| 电话 | +1 (908) 277-8000 |
| 传真 | +1 (908) 277-8412 |
| 公司简介 | C. R. Bard, Inc. and its subsidiaries (the “company” or “Bard”) are engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. Charles Russell Bard founded the company in 1907. In 1923, the company was incorporated as C. R. Bard, Inc. and distributed an assortment of urological and surgical products. Bard became a publicly traded company in 1963 and began trading on the New York Stock Exchange five years later. Currently, the company sells a broad range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities on a global basis. In general, Bard’s products are intended to be used once and then discarded or either temporarily or permanently implanted. The company participates in the markets for vascular, urology, oncology and surgical specialty products. |